A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
- Status
- RECRUITING
- Phase
- PHASE2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
The Lung Health Check Pilot
- Status
- RECRUITING
- Phase
- NA
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection
- Status
- RECRUITING
- Phase
- PHASE1
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
- Status
- RECRUITING
- Phase
- NA
Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Study of GV20-0251 in Participants With Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AI-Based Prediction of Stage and Survival in Non-Small Cell Lung Cancer: A Retrospective Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
AI Models for Predicting Occult Pleural Dissemination in NSCLC
- Status
- COMPLETED
- Phase
- N/A
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2